The effectiveness of "Cognitive Behavioral Analysis System of Psychotherapy" (CBASP) for Chronic Depressions.

The effectiveness of "Cognitive Behavioral Analysis System of Psychotherapy" (CBASP) for Chronic Depressions. - The effectiveness of CBASP for Chronic Depressions.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30104

Enrollment

165

Registered

2006-12-14

Start date

2006-10-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic (DSM-IV) Depessive disorder

Interventions

INTERVENTIONS: After the screening, all patients will be allocated at random to CBASP or to normal care. CBASP consists of 16-20 sessions spread over 12 weeks

two sessions per week in the first 4 weeks followed, in principle, by one session per week through to week 12. If establishing the therapeutic relationship proves particularly difficult, the two-we

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients (aged 18-65) can take part if they meet the DSM-IV criteria for: a) a chronic (i.e. existing for longer than 2 years) depressive disorder or b) depressive disorder superimposed on a previus dysthymic disorder or c) a recurring depressive disorder which, in the past 2 years, never went into full remission between several episodes.

Exclusion criteria

Exclusion criteria: Psychotic disorder, bipolar disorder, organic psychosyndrome, dependence on drugs or alcohol, and serious personality disorder (schizotypical, antisocial, borderline).

Design outcomes

Primary

Measure	Time frame
OUTCOME: All measures of outcomes are widely used internationally, are reliable and valid, also for usage in the Netherlands. Measurements take place at 0 weeks (pre-test) and after 12 weeks (post-test). In addition a half-year follow-up will take place after 26 weeks. The inclusion period will extend over a period of a year. The primary measure of outcomes is the IDS-C, with which the reduction in the seriousness of the depression can be measured. Patients with a complaint reduction of 50%, measured on the IDS-C, can be seen as responder.	—

Measure

Time frame

OUTCOME: All measures of outcomes are widely used internationally, are reliable and valid, also for usage in the Netherlands. Measurements take place at 0 weeks (pre-test) and after 12 weeks (post-test). In addition a half-year follow-up will take place after 26 weeks. The inclusion period will extend over a period of a year. The primary measure of outcomes is the IDS-C, with which the reduction in the seriousness of the depression can be measured. Patients with a complaint reduction of 50%, measured on the IDS-C, can be seen as responder.

—

Secondary

Measure	Time frame
Secondary measures of outcomes are the EUROquol, which measures the degree of limitation and quality of life (Dolan, 1997); the CSQ-8 which measures patient satisfaction with the interventions (de Brey, 1983); TIC-P, which tracks both absenteeism levels and the utilization of care services (www.imta.nl/publications/0261.pdf;) and health care consumption will be kept up with a diary. The measurements will be performed by research nursing staff who are blind to the treatment condition of the included patients.	—

Measure

Time frame

Secondary measures of outcomes are the EUROquol, which measures the degree of limitation and quality of life (Dolan, 1997); the CSQ-8 which measures patient satisfaction with the interventions (de Brey, 1983); TIC-P, which tracks both absenteeism levels and the utilization of care services (www.imta.nl/publications/0261.pdf;) and health care consumption will be kept up with a diary. The measurements will be performed by research nursing staff who are blind to the treatment condition of the included patients.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)